EGFR and hepatocellular carcinoma: Three particular tyrosine kinase receptors from those candidates, namely FGFR4, EGFR and PDGFRα (Fig. 3g)22,23 were reported to be highly associated with HCC occurrence and development but are not direct targets of sorafenib24.